1. Home
  2. JKS vs DBVT Comparison

JKS vs DBVT Comparison

Compare JKS & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JinkoSolar Holding Company Limited (each representing 4)

JKS

JinkoSolar Holding Company Limited (each representing 4)

HOLD

Current Price

$16.16

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$14.14

Market Cap

948.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JKS
DBVT
Founded
2006
2002
Country
China
France
Employees
N/A
90
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
948.8M
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
JKS
DBVT
Price
$16.16
$14.14
Analyst Decision
Hold
Buy
Analyst Count
5
7
Target Price
$24.80
$32.04
AVG Volume (30 Days)
560.2K
341.3K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
6.04%
N/A
EPS Growth
N/A
10.26
EPS
N/A
N/A
Revenue
N/A
$5,636,000.00
Revenue This Year
N/A
$35.04
Revenue Next Year
$14.60
$2,360.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
35.77
52 Week Low
$14.55
$8.80
52 Week High
$31.88
$26.19

Technical Indicators

Market Signals
Indicator
JKS
DBVT
Relative Strength Index (RSI) 48.94 47.20
Support Level $14.94 $12.75
Resistance Level $17.27 $14.68
Average True Range (ATR) 0.74 0.69
MACD 0.05 0.14
Stochastic Oscillator 44.27 57.45

Price Performance

Historical Comparison
JKS
DBVT

About JKS JinkoSolar Holding Company Limited (each representing 4)

JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), the Americas, Europe, Asia Pacific, and the Rest of the world.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: